FDA approves registration of ivermectin as anti-nematode drug

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

(FILE PHOTO)

Metro Manila (CNN Philippines, May 7)— The Food and Drug Administration on Friday announced it approved a company's application to register ivermectin as an anti-nematode drug.

Nematodes are roundworms.

FDA Director General Eric Domingo confirmed in a message to CNN Philippines that a certain company — Lloyd Laboratories — applied for a Certificate of Product Registration for locally-manufactured ivermectin as an anti-nematode drug.

"It was granted after they submitted data to support quality and stability of the product," Domingo said.

The pharmaceutical company is one of two local firms which earlier expressed intent to register with the FDA for ivermectin production. The other company is Pascual Laboratories Inc., according to reports.

Ivermectin is still not registered in the country for prevention or treatment of COVID-19. The FDA earlier gave six hospitals compassionate special permits to administer the anti-parasitic drug to coronavirus patients.